Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2716 to 2730 of 9098 results

  1. Topical tapinarof for treating mild to severe plaque psoriasis ID6712

    In development Reference number: GID-TA11951 Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Resmetirom for treating non-alcoholic steatohepatitis and liver fibrosis [ID6529]

    In development Reference number: GID-TA11414 Expected publication date: TBC

    Technology appraisal guidance
    In development

  3. Autologous platelet-rich plasma (PRP) injection of the lumbar facet (zygapophyseal) joints, via the intra-articular or medial branch route, for lumbar facet joint pain

    Topic prioritisation

    HealthTech guidance
    Topic prioritisation

  4. LATERA absorbable nasal implant for Nasal valve collapse causing nasal obstruction

    Topic prioritisation

    HealthTech guidance
    Topic prioritisation

  5. Cryoablation for abdominal wall endometriosis

    Topic prioritisation

    HealthTech guidance
    Topic prioritisation

  6. Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (MA review of TA781) [ID6287]: final draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 23 July 2026.

    Technology appraisal guidance
    In consultation

  7. Ciltacabtagene autoleucel for treating relapsed and lenalidomide-refractory multiple myeloma after 1 to 3 therapies (deferred appraisal of D5) [GID-TA12518]

    In development Reference number: GID-TA12518 Expected publication date:  07 April 2027

    Technology appraisal guidance
    In development

  8. Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (MA review of TA781) [ID6287]

    In development Reference number: GID-TA11484 Expected publication date:  12 August 2026

    Technology appraisal guidance
    In development

  9. Percutaneous insertion of a cerebral protection device during TAVI for preventing stroke

    In development Reference number: GID-HTG10881 Expected publication date:  11 February 2027

    HealthTech guidance
    In development

  10. Ex-situ machine perfusion devices for lung transplants

    In development Reference number: GID-HTG10878 Expected publication date:  21 October 2026

    HealthTech guidance
    In development

  11. Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]

    In development Reference number: GID-TA11572 Expected publication date: TBC

    Technology appraisal guidance
    In development

  12. Bladder cancer: diagnosis and management (update)

    In development Reference number: GID-NG10452 Expected publication date: TBC

    NICE guideline
    In development

  13. Islatravir–lenacapavir for treating HIV-1 in people with virological suppression on standard HIV-1 treatment [TSID12428]

    Awaiting development Reference number: GID-TA12475 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Iberdomide with dexamethasone and daratumumab for treating relapsed or refractory multiple myeloma after 1 or 2 lines of treatment [TSID12415]

    Awaiting development Reference number: GID-TA12466 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID6575]: final draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 9 July 2026.

    Technology appraisal guidance
    In consultation